Ligand Pharmaceuticals | LGND - Loan Capital



Ligand Pharmaceuticals reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.


Loan Capital Change Date
Amgen USD 53.76B 253M Jun/2025
Arrowhead Research USD 200.33M 8.59M Jun/2025
Baxter International USD 9.41B 962M Mar/2025
Bristol-Myers Squibb USD 44.47B 1.69B Jun/2025
Eli Lilly USD 34.18B 319.4M Jun/2025
Gilead Sciences USD 22.14B 6M Jun/2025
GlaxoSmithKline GBP 15.3B 1.17B Jun/2025
Glaxosmithkline GBP 15.3B 667M Jun/2025
Insmed USD 560.95M 567.39M Jun/2025
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
Ligand Pharmaceuticals USD 0 0 Mar/2025
MacroGenics USD 70.26M 70.26M Jun/2025
Merck USD 33.97B 484M Jun/2025
Pacira USD 378.1M 3.2M Jun/2025
Pfizer USD 57.5B 137M Jun/2025
Veracyte USD 0 0 Mar/2025